Medpace Holdings, Inc.
MEDPMedpace Holdings, Inc. is a global clinical research organization (CRO) based in Cincinnati, Ohio, employing approximately 6,000 people. Operating under a full-service model, the company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
How MEDP's past catalysts played out
No drugs found in this phase.
Frequently asked questions
When is Medpace Holdings, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Medpace Holdings, Inc. (MEDP) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track MEDP biotech catalysts?→
Add MEDP to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Medpace Holdings, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.